CLINICAL_TRIALS
trial_result
· 2016-12-06
Clinical Trial Update: Safety and Tolerability of 4975 in the Treatment of Moderate to Severe Knee Pain Due to Osteoarthritis (OA) [Phase 2]
Summary
Phase 2 trial evaluating the safety and tolerability of 4975 for moderate-to-severe knee pain due to osteoarthritis, which has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Centrexion Therapeutics | Conditions: Osteoarthritis of the Knee | Phase 2 | Status: COMPLETED